U.S. Aerovironment, Insulet, Viasat
Sept 17 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovironment, Insulet and Viasat, on Tuesday.
HIGHLIGHTS
* Aerovironment Inc AVAV.O: Raymond James cuts to market perform from outperform |
* Frontier Communications Parent Inc FYBR.O: JP Morgan cuts to neutral from overweight |
* Insulet Corp PODD.O: Piper Sandler raises target price to $285 from $230 |
* Relmada Therapeutics Inc RLMD.O: Jefferies raises to buy from hold |
* Viasat Inc VSAT.O: JP Morgan cuts to neutral from overweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Acushnet Holdings Corp GOLF.N: Jefferies cuts PT to $75 from $86 |
* Acushnet Holdings Corp GOLF.N: Jefferies cuts to hold from buy |
* Aerovironment Inc AVAV.O: Raymond James cuts to market perform from outperform |
* Airbnb Inc ABNB.O: Bernstein cuts target price to $155 from $174 |
* Alerus Financial Corp ALRS.O: Raymond James raises to outperform from market perform |
* Ani Pharmaceuticals Inc ANIP.O: Guggenheim raises target price to $83 from $77 |
* Applovin Corp APP.O: UBS raises target price to $145 from $100 |
* Applovin Corp APP.O: UBS raises to buy from neutral |
* Aramark ARMK.N: RBC raises target price to $42.5 from $36 |
* Aramark ARMK.N: RBC raises to outperform from sector perform |
* Axos Financial Inc AX.N: Raymond James cuts target price to $75 from $81 |
* Banc of California Inc BANC.N: Raymond James raises to outperform to market perform |
* Bank Ozk OZK.O: Raymond James cuts to market perform from outperform |
* Biomarin Pharmaceutical Inc BMRN.O: Bernstein cuts target price to $90 from $116 |
* Biomarin Pharmaceutical Inc BMRN.O: Jefferies cuts target price to $122 from $126 |
* Biomarin Pharmaceutical Inc BMRN.O: RBC cuts target price to $85 from $100 |
* Biomarin Pharmaceutical Inc BMRN.O: Scotiabank cuts target price to $78 from $95 |
* Biomarin Pharmaceutical Inc BMRN.O: Stifel cuts target price to $87 from $115 |
* Biomarin Pharmaceutical Inc BMRN.O: Truist Securities cuts PT to $90 from $118 |
* Biomarin Pharmaceutical Inc BMRN.O: Wells Fargo cuts target price to $90 from $115 |
* Chevron Corp CVX.N: RBC cuts target price to $170 from $180 |
* Cigna CI.N: Jefferies raises target price to $422 from $402 |
* Comerica Inc CMA.N: Raymond James raises target price to $63 from $55 |
* Deckers Brands DECK.N: Stifel adjusts PT to $147.83 from $887 to reflect 6-for-1 stock split |
* Deckers Brands DECK.N: TD Cowen adjusts PT to $176 from $1,055 to reflect 6-for-1 stock split |
* Definitive Healthcare DH.O: BTIG initiates coverage with buy rating; price target $7 |
* Dell Technologies Inc DELL.N: Mizuho initiates coverage with outperform; PT $135 |
* Dime Community Bancshares DCOM.O: Raymond James raises to strong buy from outperform |
* Evergy Inc EVRG.O: UBS raises target price to $64 from $52 |
* Exact Sciences Corp EXAS.O: BTIG raises target price to $82 from $70 |
* Exxon Mobil XOM.N: RBC cuts target price to $120 from $135 |
* Farmland Partners Inc FPI.N: Raymond James cuts target price to $14 from $15 |
* First Horizon Corp FHN.N: Evercore ISI cuts target price to $18.5 from $19.5 |
* Freightcar America Inc RAIL.O: Noble Capital raises target price to $12 |
* Frontier Communications Parent Inc FYBR.O: JP Morgan cuts to neutral from overweight |
* Frontier Communications Parent Inc FYBR.O: JP Morgan raises PT to $38.5 from $35 |
* Gannett Co Inc GCI.N: Citigroup raises to neutral from sell |
* GE Vernova Inc GEV.N: BofA Global Research raises price objective to $300 from $200 |
* GE Vernova Inc GEV.N: BofA Global Research raises to buy from neutral |
* GE Vernova Inc GEV.N: Mizuho raises target price to $241 from $208 |
* GE Vernova Inc GEV.N: RBC raises target price to $246 from $192 |
* Hartford Financial Services Group Inc HIG.N: Wells Fargo raises PT to $134 from $122 |
* Heartland Financial USA Inc HTLF.O: Raymond James raises PT to $67 from $66 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises PT to $24 from $21 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises to buy from neutral |
* Ibex Ltd IBEX.O: Baird raises target price to $23 from $20 |
* Illumina Inc ILMN.O: Leerink Partners raises target price to $160 from $150 |
* Innodata Inc INOD.O: Craig-Hallum initiates coverage with buy rating and PT $23 |
* Inseego Corp INSG.O: Stifel raises target price to $17 from $11 |
* Inseego Corp INSG.O: TD Cowen raises target price to $20 from $15 |
* Insulet Corp PODD.O: Piper Sandler raises target price to $285 from $230 |
* Jabil Inc JBL.N: Stifel cuts target price to $130 from $135 |
* Jefferies Financial Group JEF.N: UBS initiates coverage with buy rating and PT $67 |
* Kratos Defense and Security Solutions KTOS.O: Noble Capital raises PT to $26 from $22 |
* Lattice Semiconductor Corp LSCC.O: Raymond James raises target price to $55 from $50 |
* Lattice Semiconductor Corp LSCC.O: Stifel raises to buy from hold |
* Legalzoom.Com Inc LZ.O: William Blair assumes coverage with market perform rating |
* Light & Wonder Inc LNW.O: Jefferies raises target price to $128 from $116 |
* Longboard Pharmaceuticals Inc LBPH.O: Wedbush raises target price to $44 from $40 |
* Merit Medical Systems Inc MMSI.O: Needham raises target price to $109 from $105 |
* Merit Medical Systems Inc MMSI.O: Raymond James raises target price to $105 from $93 |
* Micron Technology Inc MU.O: Citigroup cuts target price to $150 from $175 |
* Micron Technology Inc MU.O: UBS cuts target price to $135 from $153 |
* Modivcare Inc MODV.O: Barrington Research cuts PT to $19 from $35 |
* Modivcare Inc MODV.O: Stephens cuts target price to $21 from $39 |
* Newmont Corporation NEM.N: UBS raises target price to $65 from $50 |
* NYCB NYCB.N: Raymond James raises to market perform from underperform |
* Old Second Bancorp OSBC.O: Raymond James cuts target price to $18 from $19 |
* Old Second Bancorp OSBC.O: Raymond James cuts to outperform from strong buy |
* Oruka Therapeutics ORKA.O: Leerink Partners initiates coverage with outperform rating; PT $44 |
* Ovintiv Inc OVV.N: RBC cuts target price to $54 from $61 |
* Prosperity Bancshares Inc PB.N: Raymond James cuts to outperform from strong buy |
* Qualcomm QCOM.O: JP Morgan cuts target price to $210 from $230 |
* Quest Resource Holding QRHC.O: Northland Capital initiates coverage with outperform rating; PT $12.5 |
* Realty Income Corp O.N: Scotiabank raises target price to $64 from $61 |
* Relmada Therapeutics Inc RLMD.O: Jefferies raises target price to $13 from $3.5 |
* Relmada Therapeutics Inc RLMD.O: Jefferies raises to buy from hold |
* Sleep Number Corp SNBR.O: Piper Sandler raises target price to $16 from $12 |
* Steel Dynamics Inc STLD.O: BMO cuts target price to $127 from $135 |
* Super Micro Computer SMCI.O: Mizuho initiates coverage with neutral rating; PT $450 |
* Synovus Financial Corp SNV.N: Raymond James raises to outperform from market perform |
* Talen Energy Corporation TLN.O: Barclays raises target price to $207 from $178 |
* Teladoc Health Inc TDOC.N: Jefferies raises target price to $10 from $8 |
* Texas Capital Bancshares TCBI.O: Raymond James raises to outperform from market perform |
* Topgolf Callaway Brands Corp MODG.N: TD Cowen cuts target price to $10 from $13 |
* UMB Financial Corp UMBF.O: Raymond James raises target price to $123 from $120 |
* Ventas Inc VTR.N: Jefferies raises target price to $73 from $66 |
* Veritex Holdings Inc VBTX.O: Raymond James raises to strong buy from market perform |
* Viasat Inc VSAT.O: JP Morgan cuts target price to $15 from $29 |
* Viasat Inc VSAT.O: JP Morgan cuts to neutral from overweight |
* Virgin Galactic SPCE.N: Morgan Stanley cuts target price to $5 from $35 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
